Monthly Archive: October 2023

Veterinary practice valuations in the third quarter have adjusted to the new economic environment, Ackerman Group co-CEO Rich Lester writes in the latest Fountain Report. Hospital valuations have stabilized in the last 15 months at a range of 8-13x EBITDA from the previous highs of 12-18x in late 2021 and early 2022, according to Ackerman Group. [...]

The FDA approved Ayradia (metronidazole oral suspension) for the treatment of Giardia duodenalis infection in dogs. According to the FDA, Ayradia is the first FDA-approved treatment for Giardia duodenalis for any animal species. Giardia duodenalis is a common protozoal parasite that can infect the intestinal tract in dogs, leading to gastrointestinal infections that commonly cause diarrhea, [...]